期刊文献+

微小RNA-224靶向Tribbles同源蛋白1调控前列腺癌细胞DU145的迁移和侵袭 被引量:2

Inhibitory effects of microRNA -224 on migration and invasion of human prostate cancer cell line DU145 by targeting Tribbles homologous protein 1
原文传递
导出
摘要 目的观察微小RNA-224(miR-224)对前列腺癌细胞DUl45迁移和侵袭能力的影响以及对靶基因Tribbles同源蛋白1(TRIBl)表达的影响。方法通过慢病毒转染前列腺癌细胞株DU145使其过表达miR-224,利用划痕实验和Transwell小室检测细胞迁移和侵袭能力;采用实时定量聚合酶链反应(Real—timePCR)和Westernblot检测细胞TRIBl表达水平的变化,并通过荧光素酶实验验证miR-224与TRIBl基因的直接调控关系。设计拯救实验并重新利用划痕实验和Transwell小室检测细胞迁移和侵袭。结果划痕实验24h后DUl45—224和DU145-vector组细胞的迁移细胞数目分别为(103.2±20.6)、(189.8±34.7)个,miR-224过表达组细胞迁移能力明显下降(P〈0.01);Transwell细胞侵袭实验显示,DUl45-224组和DU145-vector组细胞分别为(140.8±13.1)、(283.4±15.4)个,组间差异均有统计学意义(P〈0.01)。过表达miR-224后,DUl45细胞TRIBl的蛋白表达下调(P〈0.05)。荧光素酶报告实验结果显示实验组荧光素酶活性值为0.42±0.06,比对照组(0.97±0.09)显著降低(P〈0.01),提示miR-224能明显抑制TRIB1—3’端非编码区域(3’-UTR)的荧光素酶活性。拯救实验结果表明在miR-224过表达的DUl45细胞中进一步转入高表达TRIBl质粒后,迁移细胞数目为(203.2±31.2)个、侵袭细胞数目为(328.6±25.9)个,对比单纯miR-224过表达DUl45细胞[迁移细胞数目为(73.2-4-17.8)个;侵袭细胞数目为(101.2±13.1)个],迁移和侵袭能力增强,组间差异均有统计学意义(P〈0.01)。结论过表达miR-224可能通过靶向降低TRIBl基因的蛋白表达,抑制前列腺癌细胞的迁移和侵袭能力。 Objective To explore the influence of microRNA - 224 ( miR - 224 ) on migration and invasion of human prostate cancer cell line DU145 and evaluate the correlation between miR -224 and Tribbles homologous protein 1 (TRIB1). Methods After transfection of mieroRNA ]entivector into DU145 cells, cell migration and invasion were assessed by wound healing assay and Transwell chamber assay. The mRNA and protein expression level of TRIB1 was evaluated by real - time quantitative polymerase chain re- action( Real- time PCR) and Western blotting respectively. Luciferase reporter assay was used to confirm the relationship between miR - 224 and TRIB1. Rescue assay was performed to re - investigate the migra- tion and invasion of DU145 cells. Results Wound healing assay results showed that in miR - 224 transfec- tion group and empty piasmid group, the number of migrating DU145 cells was ( 103.2 -+ 20. 6 ) and ( 189.8 -+ 34. 7 ), respectively, showing a significant difference between two groups (P 〈 0. 01 ). Transwell chamber assay revealed that the number of invasive DU145 cells in miR -224 transfection group ( 140. 8 +- 13.1 ) was significantly less than that in control group ( 283.4 -+ 15.4, P 〈 0. 01 ) , indicating that miR - 224 could suppress migration ability of DU145cells. Eetopic overexpression of miR - 224 caused significant decrease of protein level of TRIB1 (P 〈 0. 05 ). In addition, luciferase assay showed that the luciferase activity of the DU145 cells 'after transfection of 3' untranslated region (3 ' - UTR) - TRIBlwt FLuci vector (0. 42± 0. 06) was reduced as compared with 3' - UTR - TRIBlmut FLuci vector group (0. 97 ±0. 09 ), suggesting the normalized TRIB1 -3'UTR luciferase activity was significantly reduced by miR - 224 ( P 〈 0. 01 ). Rescue assay identified that the re - expression of TRIB1 could respectively rescue the tumor suppressive effects of miR -224 on cell migration (203.2 ±31.2 vs. 73.2 ±17.8, P 〈0. 01 ) and invasion (328.6±25.9 vs. 101.2 ±13.1, P〈0. 01) in DU145 cells. Conclusion Overexpressed miR - 224 can inhibit migration and invasion of prostate cancer cells by downregulating TRIB1, indicating its tumor suppressive function in prostate cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第12期2939-2942,共4页 Chinese Journal of Experimental Surgery
基金 广东省自然科学基金.博士启动项目(2014A030310066) 广州市卫生局一般引导项目(20141A010013)
关键词 微小RNA.224 前列腺癌 细胞迁移 细胞侵袭 Tribbles同源蛋白1 MicroRNA - 224 Prostate cancer Cell migration Cell invasion Tribbles homologous protein 1
  • 相关文献

参考文献13

  • 1Plaisier CL, Pan M, Baliga NS. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers [ J ]. Genome Res,2012,22 ( 11 ) :2302-2314.
  • 2Mavridis K, Stravodimos K, Scorilas A. Downregulation and prognostic performance of microRNA 224 expression in prostate cancer[ J]. Clin Chem,2013,59( 1 ) :261-269.
  • 3Dangi-Garimella S ,Yun J,Eves EM, et al. Raf kinase inhibitory pro- tein suppresses a metastasis signalling cascade involving LIN28and let-7 [ J]. EMBO J ,2009,28 (4) :347-358.
  • 4Sun X, Jiao X, Pestetl TG, et al. MicroRNAs and cancer stem cells: the sword and the shield [J]. Oncogene,2014,33 (42) :4967-4977.
  • 5Zhu S,Sachdeva M,Wn F,et al. UBC9 promotes breast cell invasion and metastasis in a sumoylation-independent manner [ J ]. Oncogene 2010,29 (12) : 1763-1772.
  • 6Fellenberg J,Saehr H, Lehner B, et al. A microRNA signature differ- entiates between giant cell tumor derived neoplastic stromal cells and mesenchymal stem cells[ J]. Cancer Lett,2012,321 (2) :162-168.
  • 7Mees ST,Mardin WA,Sielker S,et al. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic duetal adeno- carcinomas[ J ]. Ann Surg Onco1,2009,16 ( 8 ) :2339-2350.
  • 8Wang Y, Lee AT, Ma JZ, et al. Profiling microRNA expression in hep- atocellular carcinoma reveals microRNA-224 up-regulation and apop- tosis inhibitor-5 as a microRNA-224-specific target [ J ]. J Biol Chem, 2008,283 (19) : 13205-13215.
  • 9Mencia N, Selga E, No6 V, et al. Underexpression of miR-224 in methotrexate resistant human colon cancer cells [ J ]. Biochem Pharma- col .2011.82 ( 11 ), 1572-1582.
  • 10Jin G,Yamazaki Y,Takuwa M,et al. Tribl and Evil cooperate with Hoxa and Meisl in myeloid leukemogenesis [J]. Blood, 2007,109 (9) :3998-4005.

同被引文献4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部